Cargando…
Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
INTRODUCTION: Non‐24‐hour sleep‐wake disorder (N24SWD) is often observed in the visually impaired and those who isolate indoors. Melatonin receptor agonists may be used for treatment, but there is currently no evidence that they are effective in patients without visual impairment. CASE: We report a...
Autores principales: | Iwata, Masaaki, Kaneko, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722683/ https://www.ncbi.nlm.nih.gov/pubmed/32990413 http://dx.doi.org/10.1002/npr2.12142 |
Ejemplares similares
-
Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020) -
Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017) -
A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008) -
Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023) -
Study on the preventive effect of ramelteon on the onset of sleep disorder after general anesthesia in patients with autism spectrum disorder: A study protocol
por: Ayuse, Terumi, et al.
Publicado: (2020)